ATHE
Price
$5.07
Change
-$0.09 (-1.74%)
Updated
Sep 3 closing price
Capitalization
78.34M
QNTM
Price
$14.05
Change
-$0.23 (-1.61%)
Updated
Sep 5 closing price
Capitalization
54.23M
Interact to see
Advertisement

ATHE vs QNTM

Header iconATHE vs QNTM Comparison
Open Charts ATHE vs QNTMBanner chart's image
Alterity Therapeutics
Price$5.07
Change-$0.09 (-1.74%)
Volume$10.52K
Capitalization78.34M
Quantum Biopharma
Price$14.05
Change-$0.23 (-1.61%)
Volume$117.66K
Capitalization54.23M
ATHE vs QNTM Comparison Chart in %
Loading...
ATHE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
QNTM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ATHE vs. QNTM commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATHE is a Buy and QNTM is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (ATHE: $5.07 vs. QNTM: $14.06)
Brand notoriety: ATHE and QNTM are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ATHE: 11% vs. QNTM: 74%
Market capitalization -- ATHE: $78.34M vs. QNTM: $54.23M
ATHE [@Biotechnology] is valued at $78.34M. QNTM’s [@Biotechnology] market capitalization is $54.23M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.56B to $0. The average market capitalization across the [@Biotechnology] industry is $1.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATHE’s FA Score shows that 0 FA rating(s) are green whileQNTM’s FA Score has 0 green FA rating(s).

  • ATHE’s FA Score: 0 green, 5 red.
  • QNTM’s FA Score: 0 green, 5 red.
According to our system of comparison, both ATHE and QNTM are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATHE’s TA Score shows that 3 TA indicator(s) are bullish while QNTM’s TA Score has 5 bullish TA indicator(s).

  • ATHE’s TA Score: 3 bullish, 3 bearish.
  • QNTM’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, both ATHE and QNTM are a good buy in the short-term.

Price Growth

ATHE (@Biotechnology) experienced а +2.63% price change this week, while QNTM (@Biotechnology) price change was -16.59% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.52%. For the same industry, the average monthly price growth was +14.52%, and the average quarterly price growth was +33.01%.

Industries' Descriptions

@Biotechnology (+2.52% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ATHE($78.3M) has a higher market cap than QNTM($54.2M). QNTM YTD gains are higher at: 281.929 vs. ATHE (53.172). ATHE has higher annual earnings (EBITDA): -19.88M vs. QNTM (-26.86M). ATHE has more cash in the bank: 4.54M vs. QNTM (1.53M). ATHE has less debt than QNTM: ATHE (106K) vs QNTM (2.27M). ATHE (0) and QNTM (0) have equivalent revenues.
ATHEQNTMATHE / QNTM
Capitalization78.3M54.2M144%
EBITDA-19.88M-26.86M74%
Gain YTD53.172281.92919%
P/E RatioN/AN/A-
Revenue00-
Total Cash4.54M1.53M297%
Total Debt106K2.27M5%
FUNDAMENTALS RATINGS
ATHE vs QNTM: Fundamental Ratings
ATHE
QNTM
OUTLOOK RATING
1..100
7151
VALUATION
overvalued / fair valued / undervalued
1..100
86
Overvalued
72
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
3836
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

QNTM's Valuation (72) in the null industry is in the same range as ATHE (86) in the Biotechnology industry. This means that QNTM’s stock grew similarly to ATHE’s over the last 12 months.

QNTM's Profit vs Risk Rating (100) in the null industry is in the same range as ATHE (100) in the Biotechnology industry. This means that QNTM’s stock grew similarly to ATHE’s over the last 12 months.

QNTM's SMR Rating (100) in the null industry is in the same range as ATHE (100) in the Biotechnology industry. This means that QNTM’s stock grew similarly to ATHE’s over the last 12 months.

QNTM's Price Growth Rating (36) in the null industry is in the same range as ATHE (38) in the Biotechnology industry. This means that QNTM’s stock grew similarly to ATHE’s over the last 12 months.

QNTM's P/E Growth Rating (100) in the null industry is in the same range as ATHE (100) in the Biotechnology industry. This means that QNTM’s stock grew similarly to ATHE’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ATHEQNTM
RSI
ODDS (%)
N/A
Bullish Trend 1 day ago
83%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 1 day ago
84%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
87%
MACD
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 1 day ago
89%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
72%
Bearish Trend 1 day ago
87%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
87%
Advances
ODDS (%)
Bullish Trend 17 days ago
72%
Bullish Trend 10 days ago
83%
Declines
ODDS (%)
Bearish Trend 11 days ago
90%
Bearish Trend 1 day ago
87%
BollingerBands
ODDS (%)
N/A
Bullish Trend 1 day ago
78%
Aroon
ODDS (%)
Bullish Trend 1 day ago
74%
Bullish Trend 1 day ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
ATHE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
QNTM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EBCOF15.53N/A
N/A
Ebara Corp.
TETUF11.16N/A
N/A
Technology & Telecommunication Acquisition Corporation
TUNGF0.73N/A
-0.30%
AMERICAN TUNGSTEN CORP.
VTKLF7.61-0.04
-0.52%
VTech Holdings, Ltd.
COOSF9.46-1.44
-13.19%
Carbios SA

ATHE and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATHE has been loosely correlated with EYPT. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if ATHE jumps, then EYPT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATHE
1D Price
Change %
ATHE100%
N/A
EYPT - ATHE
54%
Loosely correlated
+17.93%
TECX - ATHE
35%
Loosely correlated
-2.72%
GHRS - ATHE
31%
Poorly correlated
+0.28%
GLMD - ATHE
31%
Poorly correlated
+6.25%
CVM - ATHE
30%
Poorly correlated
-6.67%
More

QNTM and

Correlation & Price change

A.I.dvisor indicates that over the last year, QNTM has been loosely correlated with HYPD. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if QNTM jumps, then HYPD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To QNTM
1D Price
Change %
QNTM100%
-1.64%
HYPD - QNTM
34%
Loosely correlated
N/A
ATHE - QNTM
27%
Poorly correlated
N/A
ATAI - QNTM
26%
Poorly correlated
+0.22%
CPIX - QNTM
26%
Poorly correlated
-9.56%
DYN - QNTM
26%
Poorly correlated
+7.40%
More